Skip to main content

Home/ Groups/ OARS funding Biomed
MiamiOH OARS

PA-18-780: Development and Testing of Novel Interventions to Improve HIV Prevention, Ca... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research. For the purposes of this FOA, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected.
MiamiOH OARS

PA-18-775: Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prev... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new, revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use, the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and deaths related to impaired driving, prevent suicide attempts (nonfatal and fatal), and the drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings; and, (b) pre-trial feasibility and acceptability testing for prevention services and systems research. It is expected that research conducted via this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale drug or alcohol abuse prevention and/or drug- or alcohol-related HIV prevention intervention studies. This FOA does not support applications for which the sole focus is development of intervention protocols, manuals, or the standardization of protocols. Any intervention development work must be imbedded within a pilot/feasibility study. Of particular interest is prevention research that addresses current public health priorities and priority settings and systems.
MiamiOH OARS

PA-18-773: International Research Collaboration on Drug Abuse and Addiction Research (R... - 0 views

  •  

    This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that:
    1. Take advantage of unusual opportunities that exist outside the United States to access talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery
    2. Describe how the research will significantly advance U.S. health sciences
    3. Demonstrate specific relevance to the NIDA mission and objectives. To determine whether your research plan is relevant to the NIDA mission and objectives, review the NIDA Strategic Plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Where feasible, applications should address NIDA's international scientific priority areas (https://www.drugabuse.gov/international/research-priorities)
    4. Include an investigator from a U.S. institution and a non-U.S. citizen partner living and working in another country.
MiamiOH OARS

American College of Psychiatrists Invites Nominations for Mood Disorder Award | RFPs | PND - 0 views

  •  
    Founded in 1963, the St. Louis-based American College of Psychiatrists is a not-for-profit honorary association dedicated to providing continuing education to its members, promoting the latest advances in the field, and supporting the highest standards. To advance this mission, the college is seeking nominations for its Mood Disorders Awards.
    The annual award recognizes an individual who has advanced the understanding and treatment of mood disorders. The awardee receives a grant, certificate, travel and hotel expenses, and free registration at the ACP annual meeting.
    To be eligible, nominees must be a members of ACP in good standing.
MiamiOH OARS

Tick-Borne Disease, Career Development Award - 0 views

  •  
    The FY18 TBDRP Career Development Award (CDA) supports independent, early-career
    investigators to conduct impactful research with the mentorship of an experienced tick-borne
    diseases researcher (i.e., the Mentor) as an opportunity to obtain the funding, guidance, and
    experience necessary for productive, independent careers at the forefront of tick-borne diseases
    research. This award supports impactful research projects with an emphasis on discovery.
    Under this award mechanism, the early-career investigator is considered the Principal Investigator
    (PI), and the application should focus on the PI's research and career development. It should be
    clear that the proposed research is intellectually designed by the PI and not a product of the
    Mentor. Preliminary data are not required. However, logical reasoning and a sound
    scientific rationale for the proposed research must be demonstrated.
MiamiOH OARS

Ferring Innovation Grants - Ferring Pharmaceuticals | Ferring Pharmaceuticals - 0 views

  •  
    Ferring is committed to building a portfolio of novel, innovative drugs to address the indications of high unmet medical need for patients in our core therapeutic areas of interest.  

    The Ferring Innovation Grants are awarded annually in January and are not renewable.

    We will NOT fund clinical studies, or studies which require the collection of human samples under the direction of an Institutional Review Board.

    Proposals should only include analysis of anonymized human samples collected independently of this application.

    Therapeutic areas of interest to Ferring include:
    - Gastroenterology & Hepatology
    - Reproductive Medicine & Women's Health
    - Urology
    - Biomarker Discovery
MiamiOH OARS

LARGE-SCALE T CELL IMMUNE EPITOPE DISCOVERY - Federal Business Opportunities: Opportuni... - 0 views

  •  
    The primary purpose of this solicitation is to support highly interactive, multi-disciplinary teams, whose research efforts are focused on large-scale discovery of T cell immune epitopes associated with infectious or autoimmune diseases, and rejection of, or tolerance to, transplanted cells/organs/tissues. The discovery of epitopes associated with T cell responses to commensals and how they may be altered by the inflammatory state will also be supported by this solicitation. Validation of these epitopes and defining their role in immune protection or immune-mediated pathogenesis in humans is required. Investigators may include development/refinement of T cell epitope prediction tools as part of their research plan. It is anticipated that the multi-disciplinary teams will minimally include immunologists with the appropriate expertise in epitope identification and validation, and either microbiologists and/or virologists with expertise in the target pathogen(s), clinicians with expertise in the target autoimmune diseases, or clinicians with expertise in transplantation, as appropriate. This program will not support studies related to HIV/AIDS, or allergen epitopes, including those which are infection-related.
MiamiOH OARS

International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages collaborative research applications on drug abuse and addiction that: 1. Take advantage of unusual opportunities that exist outside the United States to access talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery 2. Describe how the research will significantly advance U.S. health sciences 3. Demonstrate specific relevance to the NIDA mission and objectives. To determine whether your research plan is relevant to the NIDA mission and objectives, review the NIDA Strategic Plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Where feasible, applications should address NIDAs international scientific priority areas (https://www.drugabuse.gov/international/research-priorities) 4. Include an investigator from a U.S. institution and a non-U.S. citizen partner living and working in another country.
MiamiOH OARS

Medication Assisted Treatment - Prescription and Opioid Addiction - 0 views

  •  
    The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2018 Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder (OUD) seeking or receiving MAT. This program's focus is on funding organizations and tribes/tribal organizations within states identified as having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and opioids, based on SAMHSA's 2015 Treatment Episode Data Set (TEDS). The desired outcomes include: 1) an increase in the number of individuals with OUD receiving MAT 3) a decrease in illicit opioid drug use and prescription opioid misuse at six-month follow-up.
MiamiOH OARS

Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) seeks grant applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness (individually or in combination). This FOA explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing; those projects should respond to a parallel set of FOAs (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).
MiamiOH OARS

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Toba... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.
MiamiOH OARS

Novel Genomic Technology Development (R21 Clinical Trial Not Allowed) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) seeks grant applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness (individually or in combination). This FOA explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing; those projects should respond to a parallel set of FOAs (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).
MiamiOH OARS

Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Tria... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new, revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use, the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and deaths related to impaired driving, and the drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings; and, (b) pre-trial feasibility and acceptability testing for prevention services and systems research. It is expected that research conducted via this R34 mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale drug or alcohol abuse prevention and/or drug- or alcohol-related HIV prevention intervention studies. This R34 FOA does not support applications for which the sole focus is development of intervention protocols, manuals, or the standardization of protocols. Any intervention development work must be imbedded within a pilot/feasibility study. Of particular interest is prevention research that addresses current public health priorities and priority settings and systems.
MiamiOH OARS

PREVENT Cancer Preclinical Drug Development Program - Federal Business Opportunities: O... - 0 views

  •  
    The purpose of this solicitation is to procure Research & Development services to support the PREVENT Program in the areas of
    (1) in vivo development/animal efficacy/biomarker development,
    (2) preclinical product development and CGMP manufacturing of biopharmaceutical agents, and
    (3) toxicology/pharmacology testing.
MiamiOH OARS

GBA Biology and Therapies | Parkinson's Disease - 0 views

  •  
    The Michael J. Fox Foundation and The Silverstein Foundation for Parkinson's with GBA will award one-to-two-year grants for GBA research to advance understanding of GBA biology and accelerate therapeutic approaches.

    This program seeks proposals for research studying:

    * How GBA mutations lead to PD
    * Mechanisms underlying GCase dysfunction in the absence of GBA mutations
    * Novel therapeutic interventions to prevent pathogenic mechanisms triggered by GCase-pathway dysfunction

    Mutations in the glucocerebrosidase (GBA) gene are one of the most common risk factors for Parkinson's disease. GBA encodes a lysosomal enzyme, beta-glucocerebrosidase (GCase). Reduced GCase activity is associated with GBA mutations and has been reported in idiopathic PD, suggesting a more general role for GCase pathway dysfunction in Parkinson's. The exact cellular mechanism by which GCase deficits contribute to the pathogenesis of PD remains unclear, warranting further investigation.

    Pre-proposal due May 31.
MiamiOH OARS

Strategic Prevention Framework - Partnerships for Success (Short Title: SPF-PFS) - 0 views

  •  

    The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP) is accepting applications for fiscal year (FY) 2018 Strategic Prevention Framework - Partnerships for Success grants. The purpose of this grant program is to address one of the nation's top substance abuse prevention priorities; underage drinking among persons aged 9 to 20. At their discretion, states/tribes may also use grant funds to target up to two additional, data-driven substance abuse prevention priorities, such as the use of marijuana, cocaine, or methamphetamine, etc. by individuals ages 9 and above. SPF-PFS is designed to ensure that prevention strategies and messages reach the populations most impacted by substance abuse. The program extends current established cross-agency and community-level partnerships by connecting substance abuse prevention programming to departments of social services and their community service providers. This includes working with populations disproportionately impacted by the consequences of substance use; i.e., children entering the foster care system, transitional youth, and individuals that support persons with substance abuse issues (women, families, parents, caregivers, and young adults).
MiamiOH OARS

Aniara Grant - 0 views

  •  
    Aniara Diagnostica's Coagulation Research Grant provides $20,000 for established investigators (eg - faculty at an academic institution) and for students/trainees to do innovative coagulation / hematology research. Deadline for receipt of application is November 1, 2018.
    The Aniara Research Panel awards one yearly $20,000 grant for specialized in hematology and coagulation research. All proposed projects must in the coagulation / hematology scientific field.
MiamiOH OARS

DoD Multiple Sclerosis, Exploration- Hypothesis Development Award Department of Defense - 0 views

  •  
    The Exploration - Hypothesis Development Award supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. The studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required.
    The proposed research project should be innovative. Innovative research may examine a novel paradigm, challenge current paradigms, look at existing problems from novel perspectives, or exhibit other highly creative qualities. Research that is an incremental advance beyond ongoing research and published data is not considered innovative and is not consistent with the intent of this award mechanism. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate how the proposed research project is innovative in the field of MS research.
MiamiOH OARS

RFA-HL-19-024: Short-Term Research Education Program to Increase Diversity in Health-Re... - 0 views

  •  
    The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by providing research experiences and related opportunities that enrich the pool of individuals from nationally underrepresented groups who will be available to compete for research opportunities in the mission areas of importance to NHLBI.
    To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences.
MiamiOH OARS

NSF/FDA Scholar-in-Residence at FDA (nsf18556) | NSF - National Science Foundation - 0 views

  •  
    The National Science Foundation (NSF), through the Directorate for Engineering, the Directorate of Computer and Information Science and Engineering Division of Computer and Network Systems, and the Directorate for Mathematical and Physical Sciences Division of Materials Research, along with the U.S. Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH), have established the NSF/FDA Scholar-in-Residence Program at FDA. This program comprises an interagency partnership for the investigation of scientific and engineering issues concerning emerging trends in medical device technology. This partnership is designed to enable investigators in science, engineering, and computer science to develop research collaborations within the intramural research environment at the FDA. This solicitation features three flexible mechanisms for support of research at the FDA: 1) Principal Investigators at FDA; 2) Postdoctoral Researchers at FDA; and 3) Graduate Students at FDA.
‹ Previous 21 - 40 of 2231 Next › Last »
Showing 20 items per page